why choose us

First received: June 07, 2023

Clinical Trial: LIAISON NES Flu A/B & COVID-19 Clinical Agreement

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Influenza A

Study Type: INTERVENTIONAL


Official Title: LIAISON NES Flu A/B & COVID-19 Clinical Agreement in Australia

Brief Summary: The DiaSorin Molecular LIAISON® NES FLU A/B & COVID-19 real-time RT-PCR assay is intended for use on the DiaSorin LIAISON® NES instrument for the in-vitro qualitative detection and differentiation of nucleic acid from influenza A, influenza B and SARS-CoV-2 virus from dry nasal swabs (NS) from human patients with signs and symptoms during the acute phase of respiratory tract infection in conjunction with clinical and epidemiological risk factors.The LIAISON® NES FLU A/B & COVID-19 assay is…

Read more